Published in World J Gastroenterol on March 21, 2005
A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health (2007) 2.50
Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. Int J Colorectal Dis (2009) 1.72
Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci (2008) 1.65
Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer (2009) 1.60
Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol (2009) 1.36
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer (2010) 1.31
High-sensitivity C-reactive protein and cancer. J Epidemiol (2011) 1.17
Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila) (2011) 1.13
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div (2009) 0.99
Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening. Br J Cancer (2012) 0.95
Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. Oncogenesis (2016) 0.93
Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation. Cancer Sci (2014) 0.93
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PLoS One (2012) 0.89
Recovery of immunological homeostasis positively correlates both with early stages of right-colorectal cancer and laparoscopic surgery. PLoS One (2013) 0.89
Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today (2014) 0.88
Inflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III Study. Eur J Nutr (2015) 0.88
C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients. Cancer Epidemiol Biomarkers Prev (2013) 0.88
Morbidity risks among older adults with pre-existing age-related diseases. Exp Gerontol (2013) 0.87
Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol (2015) 0.87
Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients. Biomark Insights (2012) 0.86
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer. Int J Colorectal Dis (2012) 0.83
Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res (2013) 0.83
Association between inflammatory potential of diet and mortality among women in the Swedish Mammography Cohort. Eur J Nutr (2015) 0.83
No Association between Circulating Levels and Genetic Variants of IL-6 and TNF-α and Colon Adenoma. Gastroenterology Res (2013) 0.81
Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. BMJ Open (2013) 0.80
Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer. Medicine (Baltimore) (2016) 0.80
Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World J Gastroenterol (2012) 0.79
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology (2016) 0.78
Preincisional versus postincisional administration of parecoxib in colorectal surgery: effect on postoperative pain control and cytokine response. A randomized clinical trial. World J Surg (2010) 0.78
Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. Dig Dis Sci (2015) 0.77
Significance of Interleukin-6 in Papillary Thyroid Carcinoma. J Thyroid Res (2016) 0.75
Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment. Int Surg (2013) 0.75
Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis. Onco Targets Ther (2015) 0.75
C-reactive protein gene rs1205 polymorphism is not associated with the risk of colorectal cancer. Biosci Rep (2017) 0.75
Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology (1990) 3.27
Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest (1989) 2.69
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res (1992) 2.64
Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res (1999) 2.17
Cytokines and the hepatic acute-phase response. Semin Liver Dis (1999) 2.17
Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res (2000) 2.07
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol (2003) 1.71
Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer (1995) 1.60
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 1.50
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol (2002) 1.33
Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol (2000) 1.33
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg (1995) 1.32
Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res (2000) 1.27
Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol (2003) 1.22
Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol (1996) 1.22
Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol (2000) 1.13
Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin Cancer Res (1998) 1.10
Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer. Cancer Res (1996) 1.03
The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res (2004) 1.00
The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer (1996) 0.99
CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res (2000) 0.99
Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res (2001) 0.93
The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res (2004) 0.92
Interleukin-6 levels in colorectal cancer tissues. World J Surg (1998) 0.90
Interleukin-6, neutrophilia and the acute phase protein response in colorectal cancer patients. Eur J Surg Oncol (1994) 0.83
Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma. Anticancer Res (2003) 0.82
The surgical pathology of rectal cancer. Am J Surg (1950) 0.81
IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells. Int J Oncol (2001) 0.81
Immunological and biochemical modulation in the treatment of advanced colorectal cancer: update and future directions. Curr Top Microbiol Immunol (1996) 0.78
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol (2010) 5.65
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53
The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis. Cardiovasc Drugs Ther (2012) 2.22
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax (2007) 1.98
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol (2006) 1.68
Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci (2007) 1.67
Abdominal desmoid tumors. Surg Oncol (2007) 1.62
Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon). BMC Surg (2006) 1.56
Allergic rhinitis, asthma, and atopy among grape farmers in a rural population in Crete, Greece. Chest (2005) 1.56
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol (2003) 1.45
Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44
Vascular-specific growth factor mRNA levels in the human diaphragm. Respiration (2005) 1.42
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma (2002) 1.31
Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg (2008) 1.28
Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26
TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol (2011) 1.18
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer (2010) 1.16
Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15
Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev (2008) 1.15
Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12
Amyand's hernia: a case report. World J Gastroenterol (2006) 1.11
Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Orbital abscess: visual loss following extraction of a tooth--case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.09
Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Peritoneal tuberculosis in pregnancy mimicking advanced ovarian cancer: a plea to avoid hasty, radical and irreversible surgical decisions. Int J Infect Dis (2009) 1.06
Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
Myoid hamartoma of the breast: a case report and review of the literature. Breast J (2007) 1.01
Primary hydatid disease of the gallbladder: a rare clinical entity. J Hepatobiliary Pancreat Surg (2004) 1.00
Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations. Int J Dermatol (2011) 1.00
Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int Surg (2007) 0.99
Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99
Celiac artery stenosis: an underappreciated and unpleasant surprise in patients undergoing pancreaticoduodenectomy. J Am Coll Surg (2007) 0.98
Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol (2002) 0.98
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
An extended retroperitoneal abscess caused by duodenal diverticulum perforation: report of a case and short review of the literature. Am Surg (2007) 0.97
Facial trauma in the Trojan War. Oral Maxillofac Surg (2014) 0.96
Clinical considerations of primary hydatid disease of the pancreas. Pancreatology (2005) 0.96
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J Cell Physiol (2005) 0.95
Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis (2010) 0.95
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol (2011) 0.95
Muc4/MUC4 functions and regulation in cancer. Future Oncol (2009) 0.95
Primary melanoma of the gallbladder: does it exist? Report of a case and review of the literature. World J Gastroenterol (2006) 0.95
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94
Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol (2010) 0.94
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis (2006) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Transanal polypectomy using single incision laparoscopic instruments. World J Gastrointest Surg (2011) 0.92
Gracilis myocutaneous flap: evaluation of potential risk factors and long-term donor-site morbidity. Microsurgery (2011) 0.92
Association of allergic rhinitis with pesticide use among grape farmers in Crete, Greece. Occup Environ Med (2006) 0.92
Mechanisms and natural history of pain in chronic pancreatitis: a surgical perspective. J Clin Gastroenterol (2007) 0.92
The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res (2004) 0.92
The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit (2012) 0.91
Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol (2012) 0.91
Alternative bi-pectoral muscle flaps for postoperative sternotomy mediastinitis. Ann Thorac Surg (2006) 0.91
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine (2013) 0.90